Erik Nerpin

Erik Nerpin is a Swedish lawyer and private investor specializing in corporate finance and governance. He holds a Bachelor of Laws from Uppsala University and a Master of Laws from Boston University. As the founder of Advokatfirman Nerpin AB, he has extensive experience in business administration, corporate governance, and stock exchange matters. In addition to his legal practice, Nerpin serves as the chairman of several companies, including Diamyd Medical Aktiebolag, Kancera AB, Blasieholmen Investment Group Equity AB (publ), Blasieholmen Investment Group Seed AB (publ), Wicket Gaming AB, and Hilbert Group AB (publ). He is also a board member of EffNet AB, Blasieholmen Investment Group AB, Naihsadrak AB, Advokatfirman Nerpin AB, Kancera Förvaltning AB, Ittot AB, Sallisac AB, Effnetplattformen Holding AB, and Identity Devices Sweden Holding AB. Nerpin's investment activities encompass a wide range of asset classes, including private equity, venture capital, real estate, hedge funds, commodities, cryptocurrencies, fixed income, infrastructure, collectibles, distressed situations, and ESG and impact investing. His investment strategy targets various stages of company development, from seed and early-stage investments to growth, late-stage, pre-IPO, buyouts, turnarounds, and distressed assets. Geographically, his investments span multiple countries, including Sweden, the United States, the United Kingdom, Germany, France, and others. His industry focus is diverse, covering sectors such as technology, healthcare, real estate, financial services, consumer goods, energy, telecommunications, media, transportation, education, agriculture, manufacturing, retail, hospitality, and construction.